Member Info for elrico

The biggest clue someone has an agenda is when simply providing the mere basic info refutes they apparently overlook the silliness of the key component of their case. Why would anyone seek to waste their own time when all they do is make themselves look foolish. It is a poor strategy if the objective is to be taken seriously.

Munchbox, allow me to assist you with your research.

Pay attention to the podcast, there are clues in there for you, should you chose to pin your ears back. https://lemminginvestors.blogspot.com/2020/12/skinbiotherapeutics-commercial-realty.html

And there's this... Pay attention to the date and amount. You may choose to run a calculator over the accounts to establish cash burn. ??
https://www.skinbiotherapeutics.com/proposed-placing-and-open-offer/

StarJump,

With respect. You clearly do not understand OPTI, its IP, business model or sectors. I'd stick to 4D mate.

It could well be more. However, since the merger with W2T the headcount and thus cash burn will increase. The company does not run on air, there are costs. I suggest you familiarise yourself with them and ask why W2T were forever being paid with shares. Look at the regularity of this. You have to remember Protus maybe the first of possibly 10 sites in the UK. Be realistic with your scope of revenues and when they arrive.

To my knowledge, the company has offered no revenue guidance for 2021/22 BECAUSE THEY CAN'T.

Technical traders will be dumping soon enough, chase it up is a big risk from here. I know, I have seen this sort of nonsense more times than I care to remember of 36 years.

Kenny, nice Buffet quote. Sadly, it does not change the valuation argument does it. If it does, please explain it to me, I will read it on the next tube ride - subject to government house arrest.

Seriously! Do the maths for God sake. PHE is already valued at £368 million. It has perhaps £2m, and the earliest revenues will be when exactly and at what scale when each DMG expects to reap £500k pa.
Accept you have had a fantastic run in 2020, I have played my part in this....before you start with the mud-slinging.

BTW. ************* readers have PHE 3rd on the shortlist.
https://twitter.com/LEMMINGINVESTOR/status/1345505730330324993

https://lemminginvestors.blogspot.com/2021/01/my-2021-picks.html

The 24-hour data from the blog is very encouraging.

See screengrabs from the blog. The top is for the article itself and the second appears to be the wider exploration of the blog. There has been a surge in SBTX keyword search.
https://twitter.com/LEMMINGINVESTOR/status/1345505730330324993

You may like to know SNG has resulted in quite a few PM. The 24-hour data from the blog is very encouraging. There are quite a few potential new investors.

See screengrabs from the blog. The top is for the article itself and the second appears to be the wider exploration of the blog.
https://twitter.com/LEMMINGINVESTOR/status/1345505730330324993

One level down from the grammar police. I tip my hat to you, sir. ??

Would you prefer me to go over the same ground everyone else is? The wearable may seem like a pipedream to you now, but you will see in short order it will derive more revenues from vaccines if my assumptions prove correct.

There are 2 articles on the blog that focus on specific areas of OO. Regular readers will be well aware. The point of the short pieces was my opinion what will drive the SP in the short term. You didn't need to read between the lines, you just needed to pay attention.

Some data for you to whine about.
https://twitter.com/LEMMINGINVESTOR/status/1345505730330324993

It appears most readers read beyond the first para of my 4D musings. Some of the natives on ADV did not or chose to focus on the first para and not the article as a whole. They even failed to note I placed 4D ahead of what has been my favourite stock for potential if the company delivers and the wider market appreciates it...OPTI. Essentially, I was clearly suggesting there is more value to be had from 4D.

Here is some data on the readership for just 24 hours. How many are already invested I do not know.
https://twitter.com/LEMMINGINVESTOR/status/1345505730330324993

I would have much preferred a copy paste a para then link back. This helps my efforts.
https://twitter.com/LEMMINGINVESTOR?s=09

https://lemminginvestors.blogspot.com/2021/01/my-2021-picks.html?m=1

https://lemminginvestors.blogspot.com/2021/01/my-2021-picks.html?m=1

https://lemminginvestors.blogspot.com/2021/01/my-2021-picks.html?m=1

https://lemminginvestors.blogspot.com/2020/12/skinbiotherapeutics-huge-2021-is.html?m=1

https://lemminginvestors.blogspot.com/p/happy-christmas.html ????????????????

https://lemminginvestors.blogspot.com/2020/12/open-orphan-renews-contract-with-top-3.html

It comes down to vision. CF clearly understood what Venn has under the bonnet, Venn BOD did not. You can argue CF got lucky, that would be harsh. https://lemminginvestors.blogspot.com/

With respect, wooli....you make the same point time and again. You do so while ignoring additional products are being launched by partners that are in a far better position than you to judge. We get you are not convinced, fine.

You also ignore more vaccines are being made ready and I am sure more will follow. When the world eventually returns to some normality more and more people will be looking at healthier options, paying special attention to healthy labels, and yes, this includes pre and probiotics that are science-backed, proven to have health benefits. Cardiovascular health will be at the forefront of this trend, as will weight management, given these two area's have proven a major factor for the poor souls that lost their lives through Covid-19.

You also appear to have taken your eye of the 24% holding OPTI has in SBTX. A huge mistake. Here is why.
https://lemminginvestors.blogspot.com/2020/12/skinbiotherapeutics-ceo-stuart-ashman.html

Do you imagine OPTI not benefitting from the very likely growth in the market valuation of its investment in SBTX, which it has a free ride on. It is on the books for zero now OPTI has sold the cash equilent to fund Optipharm and H&B.

I have added an addendum after clarifying a point with SA TODAY.

https://lemminginvestors.blogspot.com/2020/12/skinbiotherapeutics-ceo-stuart-ashman.html